Literature DB >> 1591265

Prevalence and severity of malocclusion in children with cleft lip and/or palate in Hong Kong.

E L Tang1, L L So.   

Abstract

The prevalence and severity of malocclusion among children with cleft lip and palate in Hong Kong has never been assessed or documented. A group of 20 children in the primary or early mixed dentition stages, with clefts of the lip and/or palate were assessed using the Occlusal Index. Results of this preliminary study showed that 92.3 percent of the male and 71.5 percent of the female subjects had severe malocclusion, which implied that comprehensive orthodontic treatment at a later stage would be needed. More than half (69.2% of the male, and 57.1% of the female subjects) had syndrome F, defined as mesial molar relationship, overjet, overbite, posterior crossbite, midline diastema, and midline deviation (Summers, 1966). Therefore malocclusion problems were shown to manifest early in patients with cleft lip and/or palate, and further that it is possible to assess malocclusion prevalence and severity in early stages of dental development.

Entities:  

Mesh:

Year:  1992        PMID: 1591265     DOI: 10.1597/1545-1569_1992_029_0287_pasomi_2.3.co_2

Source DB:  PubMed          Journal:  Cleft Palate Craniofac J        ISSN: 1055-6656


  3 in total

1.  Occlusal disorders among patients with total clefts of lip, alveolar bone, and palate.

Authors:  Anna Paradowska-Stolarz; Beata Kawala
Journal:  Biomed Res Int       Date:  2014-05-27       Impact factor: 3.411

2.  Preliminary study of Korean orthodontic residents' current concepts and knowledge of cleft lip and palate management.

Authors:  Il-Sik Cho; Hyo-Keun Shin; Seung-Hak Baek
Journal:  Korean J Orthod       Date:  2012-06-28       Impact factor: 1.372

3.  Assessing Angle's malocclusion among cleft lip and/or palate patients in Jammu.

Authors:  Akshay Gupta; Anur Gupta; Amit Bhardwaj; S Vikram; Ajeetha Gomathi; Karanprakash Singh
Journal:  J Int Soc Prev Community Dent       Date:  2016-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.